Tag: antidepressants

Researchers find that most psychiatric drugs cause severe withdrawal despite attempt s to gradually decrease the dosage.

“This is remarkable for drugs that are used to treat depressive symptoms,” write the researchers.

With these twelve facts, you are equipped to defend against the misinformation propagated by academic psychiatry, Big Pharma, and the laypeople they target. You are encouraged to use this knowledge to (firmly but respectfully) challenge statements you hear in passing or from loved-ones such as “He is mentally ill,” “I have a chemical imbalance and these drugs help correct it,” or any other commonly accepted falsehoods that the above facts expose.

Researchers suggest that because most antidepressant “success” is due to the placebo effect, they may never find a way to predict outcomes.

Trials of antidepressants for relapse prevention are confounded by withdrawal effects caused by the drugs.

A new study indicates that popular online resources do not accurately present the scientific evidence on the risks and benefits of antidepressants.

New study finds that Medicaid enrolled youth were 14 times more likely to be on an antidepressant in 2014 than in 1987.

Researchers at Johns Hopkins test paroxetine on developing brain cells and discover numerous neurotoxic effects.

There are three steps to modern psychiatry’s successful business formula: 1. Get people to think that they’re stupid even though they’re smart. 2. Train them to actually think stupidly. 3. Directly stupidify them with chemicals.

Researchers confirm that the suicide warning for antidepressants is justified by the evidence and that claims that the warning is harmful lack support.

Researcher criticizes the many ways opposing viewpoints and dissenting voices are squashed in the field of medicine.

Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.

In a new study, researchers found no evidence of antidepressant group variance, which means that there's no particular group of patients who improve more than others on the drug.

A review of 73 antidepressant studies finds that 12% more people drop out of clinical trials when taking antidepressants than when taking placebo, evidence that many find the adverse effects of antidepressants difficult to tolerate.

An issue of Lancet Psychiatry is devoted to clarifying the lack of efficacy for Zoloft (sertraline).

New research contends that ketamine can reduce problematic alcohol use but does the data support the claims?

A new special issue brings together articles exploring the harmful effects of simultaneous multiple medication use.

Young women’s narratives indicate ways antidepressants have shaped their sense of self.

Researchers compared the efficacy of antidepressants using different rating scales and found them to be no different—just slightly better than placebo, and not meeting the criteria for clinical significance.

The use of antidepressants has risen quickly among older adults but the rate of depressive symptoms in this population has not declined as a result.

Researchers interviewed people who were given medical advice to discontinue antidepressants.

A Nigerian study finds that more than three-quarters of patients improved, even when only 13% were prescribed medication.

A clinical trial finds Prozac no better than placebo for improving repetitive behaviors.

Researchers shed light on the precarious nature of evidence from efficacy trials of antidepressant medication to treat symptoms of major depressive disorder in children and adolescents.

A new update to the NICE guideline for depression suggests providers discuss long-term, severe antidepressant withdrawal symptoms.